Beta-interferon and glatiramer acetate were effective for the treatment of multiple sclerosis, with cost-effectiveness ranging from £7000 to £34,000 per quality-adjusted life-year.
http://ift.tt/2xpWfMn
Πέμπτη 21 Σεπτεμβρίου 2017
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου